Semax Results Timeline
What the standard Semax research protocol looks like phase by phase, over a typical 2–4 weeks (intensive) or 8–12 weeks (gradual) cycle. This is the escalation schedule from our full dosing protocol, presented as a timeline rather than a table.
Quick Facts
FREQUENCYOnce daily or every other day
CYCLE LENGTH2–4 weeks (intensive) or 8–12 weeks (gradual)
DOSE RANGE0.5–3.0 mg/day
ROUTESubcutaneous injection
Phase-by-Phase Timeline
Loading / Titration
Weeks 1–2
Target dose: 0.5 mg (500 mcg)
Escalation
Weeks 3–4
Target dose: 1.0 mg (1,000 mcg)
Maintenance
Advanced
Target dose: 3.0 mg (3,000 mcg)
Reported in Research
- ✓Intensive short courses (2–4 weeks) are common.
- ✓Intensive: 2–4 weeks.
- ✓Gradual: 8–12 weeks.
This timeline reflects the structure of the standard Semax research protocol documented on this site — it is not a guarantee of individual outcomes, and timelines vary between research subjects. All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.